Your metabolic snapshot
Your pattern profile
What your numbers are telling you
What to watch next quarter
Conversation starters for your provider
Your next step
This educational summary reflects published research on population-level patterns in women with PMOS (PCOS). It is not an interpretation of your individual health status and does not constitute medical advice. Your healthcare provider is the appropriate person to interpret your lab results in the context of your full clinical picture.
In May 2026, a global consensus of 56 medical and patient organizations officially renamed PCOS to PMOS — polyendocrine metabolic ovarian syndrome. The science hasn't changed; the name simply reflects what the research has long shown: this is a whole-body hormonal and metabolic condition, not just an ovarian one. We use PMOS throughout. You'll still see "PCOS" widely during the multi-year transition — they refer to the same thing.
This report is for educational purposes only. It does not diagnose any condition or constitute medical advice. Always work with your healthcare provider for medical guidance specific to your situation.
Your glucose looks stable — but your insulin numbers suggest it's working overtime.
Your fasting glucose and HbA1c are in a good range — so technically, those numbers passed. Fasting insulin isn't included on most standard lab panels, and even when it is, the "normal" cutoff was designed for the general population, not specifically for people with PMOS. Your insulin came back at 14.2. It's within the standard range. But it's also nearly double the level where PMOS research has found hormone-related symptoms beginning. This report addresses that gap.
Here's what your numbers describe together: your insulin is running higher than it typically needs to be to keep your blood sugar steady. In the research, that pattern is closely tied to your hormones — elevated insulin is one of the most well-documented suppressors of SHBG (Sex Hormone Binding Globulin), the protein that normally keeps testosterone in check. When SHBG drops, more testosterone becomes active and free to reach your tissues. Your inflammation marker is also sitting just above the low-risk target, which research describes as reinforcing the same insulin pattern.
This is one of the most studied patterns in PMOS research — and the rest of this report walks you through what it means, marker by marker, and the options the research points to so you can talk them through with your doctor.
Three numbers outside of a good range
What each one means, what it might explain about how you've been feeling, and why it may not have shown up as a problem on your standard lab report.
The cutoff for "normal" on most lab reports is based on where the general population falls — not a target for what your hormones need to work well when you have PMOS. Research specifically on PMOS has found that certain numbers need to be in a tighter range to avoid hormone-related effects, even when they technically "pass" on a standard panel. Each card below explains exactly where that difference is.
Standard "normal" on your lab report: 2–25 · PMOS research has found effects above: 8–10 · Your HOMA-IR score: 3.24
Insulin is a hormone your pancreas makes to move sugar from your blood into your cells. Fasting insulin is measured before you eat — it shows how much your body is producing just to stay stable at rest. Your result of 14.2 means your body is working roughly twice as hard as it typically would at rest, just to maintain blood sugar without any food in your system.
- An energy crash 2–3 hours after eating
- Cravings that feel physical and urgent, not just habit
- Weight that won't budge despite eating reasonably
- Difficulty concentrating in the afternoon
When insulin stays elevated, it sets up a spike-and-crash blood sugar pattern that drives afternoon fatigue and intense cravings. It also directly reduces SHBG production in your liver — which is the chain reaction connecting your insulin level to the hormonal symptoms you may be seeing on your skin, hair, or cycle.
Your HOMA-IR score — calculated from your insulin and glucose using (Insulin × Glucose) ÷ 405 — is 3.24. Published PMOS research has associated scores above 2.0 with a meaningful pattern of insulin resistance. Your score is above that level, though your healthcare provider is the right person to determine what this means for your individual care.
Your value of 14.2 falls within the standard "normal" range of 2–25, so it likely wasn't flagged. PMOS research has found that values above 8–10 are associated with the hormonal effects that cause symptoms in this condition. The general-population cutoff wasn't built with PMOS in mind.
Standard "normal" on your lab report: 17–120 · PMOS research has found hormone effects below: 70–80 · Your free testosterone: 4.2 pg/mL, also elevated
SHBG — Sex Hormone Binding Globulin — is a protein your liver produces that attaches to testosterone in your blood and keeps it inactive while it's in transit. Think of it as a holding mechanism: testosterone bound to SHBG can't reach your tissues or cause effects. Only "free" (unbound) testosterone is biologically active. When SHBG is low, more testosterone is free and active — even when your total testosterone number looks normal on paper.
Elevated insulin is a well-documented suppressor of SHBG production in the liver. This is one of the most replicated mechanisms in PMOS research — it's the direct link between your insulin number and the hormonal effects below.
- Acne along the jaw, chin, or back
- Hair thinning at the crown or temples
- Increased facial or body hair
- Irregular or missed periods
Your total testosterone of 62 ng/dL is within the normal reference range. But your free (active) testosterone is elevated at 4.2 pg/mL because your low SHBG isn't holding enough of it back. The acne, hair changes, and cycle irregularities may all trace back to this same chain: elevated insulin → reduced SHBG → more active testosterone reaching your tissues.
This is importantly not a testosterone production problem. It's a testosterone regulation problem, caused by the insulin situation. Research consistently shows that as insulin resistance improves, SHBG typically rises — and the androgen effects tend to follow.
Your value of 28 falls within the standard "normal" range of 17–120, so it likely wasn't flagged. PMOS research has found that values below 70–80 are associated with androgen-related symptoms, even when the number technically passes on a standard panel.
Standard concern level: above 3.0 · Low-risk target (American Heart Association): below 1.0
hsCRP — high-sensitivity C-Reactive Protein — is a protein your liver produces whenever there's inflammation in your body. The high-sensitivity version is designed to detect low-level, chronic inflammation — the quiet kind that doesn't cause obvious symptoms but affects how well your body functions over time. Your result of 1.8 is below the level most doctors consider a clinical concern, but above the low-risk target from cardiovascular research.
- Fatigue that sleep doesn't fix
- Mood that feels slightly off, consistently
- Feeling "wired but tired" at night
- Sleep that isn't restorative even when you get enough hours
Research on PMOS has found that chronic low-grade inflammation and insulin resistance tend to co-occur and reinforce each other — inflammation reduces how effectively cells respond to insulin, which raises the insulin burden, which worsens inflammation. Your hsCRP of 1.8 is consistent with this pattern.
Studies consistently show that hsCRP tends to fall alongside improvements in insulin resistance. Adding omega-3 fatty acids (EPA/DHA) at 2–4 grams daily has specific evidence for reducing hsCRP and is worth discussing with your provider.
Your value of 1.8 is below the clinical concern level of 3.0, so it likely passed without comment. The low-risk target of below 1.0 comes from cardiovascular research, and PMOS studies suggest that values in the 1–2 range have metabolic effects when chronically elevated.
The good news your labs are also telling you
Not everything here needs attention — and what's working is just as important to see. These markers show where you have a real head start, and how much room there is to build on it.
Blood sugar stable at rest. You're at the stage where insulin is elevated but glucose hasn't followed yet — the earlier and more responsive stage for making changes.
90-day average blood sugar is genuinely optimal. Confirms the insulin elevation is a hormonal pattern, not a blood sugar crisis — which shapes which approaches are most appropriate.
Within range. The androgenic symptoms are driven by low SHBG making more testosterone active, not by overproduction. An availability problem, not a production problem — they have different solutions.
metabolic pattern
Insulin elevated, glucose preserved. The stage where lifestyle and nutritional approaches have the most published evidence behind them. Best-case scenario for making a meaningful difference.
What your numbers are showing as a whole
Not individual markers in isolation — the chain of events connecting them. This is what the appointment doesn't have time to walk through.
Here's the sequence, in order: your pancreas is producing extra insulin to keep your blood sugar stable. That elevated insulin signals your liver to produce less SHBG. With less SHBG, more testosterone stays unbound and active — free to reach your skin, your hair follicles, your ovaries. This is why a blood sugar issue causes hormonal symptoms in PMOS. It's one connected chain, not several separate problems.
The acne along your jaw, the hair changes, the cycle irregularities — in the research, these often aren't separate issues. They tend to trace back to the same chain: when insulin rises, SHBG falls, and more active testosterone reaches the tissues. It's why the insulin piece comes up so often as the thread connecting the rest.
Your hsCRP is running alongside this and making it harder. Chronic low-grade inflammation reduces how effectively your cells respond to insulin — which makes your body produce even more of it — which keeps the inflammation going. The starting points in the next section address multiple entry points in this loop simultaneously.
reduce SHBG
unbound & active
Your hsCRP (1.8 mg/L) adds to this picture. Inflammation and insulin resistance reinforce each other — elevated inflammation impairs insulin receptor sensitivity, and insulin resistance promotes inflammatory signaling. Research consistently finds that as insulin resistance improves, hsCRP tends to fall alongside it.
The options worth knowing about — and the research behind them
Here's what the published research actually explores for a pattern like yours — the why behind each one, in plain English. These are options to understand and discuss with your doctor, not prescriptions, and everyone's situation is different. But you'll leave this section knowing what's out there and why it matters, instead of guessing.
The general idea is to make protein the first thing eaten in the morning — around 30 grams. Eggs, Greek yogurt, cottage cheese, or a clean protein shake all work. It's not about cutting carbs — just about sequencing protein first.
When insulin is already elevated, the body tends to be most insulin-resistant in the morning, so blood sugar can swing more easily. Research suggests that eating protein before carbohydrates can slow how quickly blood sugar rises afterward, which is associated with a smaller insulin response to the meal. It's one of the more studied ways to soften the spike-and-crash pattern many people describe.
People often describe steadier afternoon energy and fewer mid-afternoon cravings over a few weeks. These are subjective changes, not a measure of any lab value — and individual experiences vary widely.
Within about 30 minutes of waking, get outside for 5–10 minutes of natural light — no sunglasses, no window glass in between. Cloudy days still count; outdoor light is many times brighter than indoor light even when it's grey. Pair it with your morning coffee if that makes it stick.
This is one many people haven't connected to PMOS. Morning light helps set the circadian clock, which research links to the daily rhythm of cortisol and insulin sensitivity. Studies suggest that when that rhythm is disrupted — too little morning light, too much light at night — cortisol and insulin signaling can be affected. It's a low-cost area that gets relatively little attention.
People often report easier mornings and a more natural wind-down at night within a week or two. Sleep quality is itself associated with insulin sensitivity in the research. Experiences vary from person to person.
The general idea is an easy 10-minute walk roughly 15–30 minutes after the largest meal. It's not framed as exercise or calorie-burning, but as timing movement to when blood sugar tends to peak.
Physiology research describes how working muscles can take up glucose from the blood through a pathway that doesn't require insulin. Walking when blood sugar tends to be highest is therefore associated with a smaller insulin response to that meal. Some studies have linked regular post-meal walking to improvements in measures of insulin resistance over several weeks.
People often describe less post-meal heaviness and fewer cravings afterward. It's among the more consistently studied of these topics. Any effect on lab values would only be visible at a future recheck, and varies by individual.
The general idea is 15–20 minutes a day of bare skin in contact with natural ground — grass, soil, sand, or untreated stone. Morning pairs naturally with the light topic above. It can be done sitting, standing, or walking.
Low-grade inflammation (reflected in markers like hsCRP) is described in the research as interacting with insulin resistance. Grounding, or "earthing," is one of the more exploratory, less conventional topics here. Early studies have associated direct contact with the earth with lower markers of inflammation and a calmer nervous-system state, though the evidence base is still small. It's included as a low-risk area some people choose to explore, not as an established intervention.
This is more often described subjectively — people report feeling calmer and sleeping more deeply. Any inflammation marker like hsCRP would only be reflected at a future recheck, and the research here is still early.
Red light therapy
This one's more emerging than established, but it's promising enough to put on your radar. Red and near-infrared light (10–15 minutes a few times a week) is thought to support the mitochondria — the tiny engines inside your cells that produce energy. Since insulin resistance is partly a story of cells struggling to use energy efficiently, there's a real mechanistic reason researchers are curious here, and early studies have linked it to better insulin sensitivity and lower inflammation. Treat it as an experiment, not a cornerstone: the habits above have far more evidence behind them. But if you're someone who likes to explore the edges, this is a thoughtful place to start.
Where supplements fit — and the question most people get backwards
In the research, the supplements studied for a pattern like yours tend to cluster into two areas: insulin-signaling support (compounds studied for how cells respond to insulin) and inflammation support (relevant to the hsCRP piece). That's the direction the evidence points for these markers.
But here's what most people get backwards: more bottles isn't better, and some popular PMOS supplements may do little for your specific pattern — or even work against it. Before adding anything new, the smartest first move is understanding whether what you're already taking is helping, redundant, or counterproductive given your numbers. That's exactly what the Supplement Stack Audit is built to do.
Your recheck roadmap — 8 to 12 weeks from now
These three values will tell you whether the pattern is actually shifting. Order them at your next blood draw and compare them to this report.
Recalculate your HOMA-IR: (Insulin × Glucose) ÷ 405. This is your most direct measure of whether the insulin resistance pattern is improving. Published PMOS research has associated scores above 2.0 with meaningful insulin resistance — aim for movement toward and below 2.0.
Looking for: HOMA-IR moving toward 2.0 or belowSHBG responds slowly to insulin changes. Even a 5–10 nmol/L increase confirms the upstream lever is working. Watch for gradual movement upward toward 40, then higher over subsequent rechecks.
Looking for: SHBG beginning to rise above 35–40 nmol/LTends to fall alongside improvements in insulin resistance. Adding omega-3 fish oil at 2–4 grams of combined EPA and DHA per day may help this move faster. Low-risk target: below 1.0 mg/L.
Looking for: hsCRP falling below 1.0 mg/LDHEA-S — an adrenal hormone not included in your current results. Knowing whether it's elevated would clarify whether there's an adrenal contribution to your androgen pattern, which affects which approaches are most relevant. Vitamin D (25-OH) — low vitamin D is prevalent in people with insulin resistance and PMOS, and research suggests it can impair insulin signaling. Both are standard additions to a blood draw.
You walked in with labs that technically passed, and you still knew something wasn't right. You weren't imagining it. "Normal" and "working well for your body" are two different things, and the space between them is where PMOS quietly lives. Now you can finally see your full picture in one place — what each number means, how the research connects them, and the options worth bringing to your doctor. No more midnight rabbit holes. Your labs are a snapshot of one moment, and moments change — so think of this as your starting line, not the finish.
Your Doctor's Guide
Your lab values alongside PMOS research context and published citations — to support a more informed conversation with your provider, not to replace their clinical assessment.
| Marker | Your value | Standard lab range | PMOS research context | Status |
|---|---|---|---|---|
| Fasting Insulin | 14.2 μIU/mL | 2–25 μIU/mL | PMOS research has found hormone effects associated with values above 8–10 μIU/mL | Above PMOS research range |
| HOMA-IR (calculated) | 3.24 | Not routinely reported | Published PMOS research has associated scores above 2.0 with meaningful insulin resistance | Elevated per published criteria |
| Fasting Glucose | 92 mg/dL | 70–99 mg/dL | Within good range; glucose preserved while insulin is elevated | Good range |
| HbA1c | 5.4% | Below 5.7% | Good range; 90-day average blood sugar is optimal | Good range |
| SHBG | 28 nmol/L | 17–120 nmol/L | PMOS research has found androgen-related effects associated with values below 70–80 nmol/L | Below PMOS research range |
| Free Testosterone | 4.2 pg/mL | 0.1–6.4 pg/mL | PMOS research has associated values above 3.4–4.0 pg/mL with androgenic effects | Elevated per published criteria |
| hsCRP | 1.8 mg/L | Below 3.0 mg/L | AHA low cardiovascular risk target: below 1.0 mg/L; PMOS research associates chronic mild elevation with worsened insulin sensitivity | Above low-risk target |
Landmark review establishing insulin resistance as central to PCOS, affecting an estimated 50–70% of affected women regardless of BMI. Specifically describes how hyperinsulinemia directly suppresses hepatic SHBG synthesis — the mechanistic basis for the insulin-SHBG-androgen chain in this patient's results.
Found HOMA-IR above 2.0 to be associated with clinically relevant insulin resistance in PCOS women — providing context for this patient's HOMA-IR of 3.24.
Prospective study of 254 women with PCOS finding significantly higher rates of impaired glucose tolerance compared to controls — supporting early identification of the insulin pattern at the stage this patient presents.
Demonstrates the direct suppressive effect of insulin on SHBG gene expression in hepatic cells — establishing the mechanism by which hyperinsulinemia reduces SHBG production. This patient's low SHBG is consistent with secondary suppression by elevated fasting insulin.
AACE guidelines recommending SHBG measurement in PCOS evaluation, noting correlation with insulin resistance and the resulting increase in biologically active androgens — supporting the clinical relevance of this patient's SHBG and free testosterone values.
Finds CRP significantly elevated in PCOS women compared to BMI-matched controls, and that this inflammatory state both reflects and potentiates insulin resistance — consistent with this patient's co-occurring HOMA-IR elevation and mildly elevated hsCRP.
Systematic review finding elevated inflammatory markers including CRP in PCOS women independent of BMI. Supports clinical attention to hsCRP below the standard clinical concern threshold in PCOS patients.
Systematic review finding consistent associations with improvements in fasting insulin, HOMA-IR, and — in several trials — increases in SHBG. Authors conclude myo-inositol is a safe and well-tolerated approach to the metabolic component of PCOS, particularly relevant for insulin-predominant presentations.
Systematic review finding that structured exercise — including resistance training — improves insulin sensitivity and reduces HOMA-IR in PCOS independent of weight change. Supports resistance training as a first-line non-pharmacological intervention for insulin resistance.
This summary was prepared by Kascade Health LLC, a health education and self-monitoring platform (kascadehealth.com). Intended to support an informed patient-provider conversation based on published PMOS research. Does not constitute medical advice, a clinical assessment, or a diagnosis. All references are to peer-reviewed published literature. Patient values are self-reported. Clinical decisions should be made by a qualified healthcare provider based on a full individual assessment. © 2026 Kascade Health LLC.
Want to know if your current supplements are helping or working against this pattern?
The Supplement Stack Audit analyzes everything you're taking against your specific lab results — what the research supports for your pattern, what's redundant, what might be missing, and anything that could be working against you. The $50 bundle rate closed at checkout — adding it now is $97 standalone.
Questions about the report
The cutoffs on standard lab reports are based on where the general population falls. For PMOS specifically, researchers have found that certain markers need to be in a tighter range to avoid hormone-related effects — and those tighter ranges aren't reflected on most standard panels. A fasting insulin value can be within the standard "normal" range but still well above the level where PMOS research has found hormone effects beginning. This report applies those PMOS-specific research findings.
HOMA-IR is a calculated score that estimates insulin resistance: (Fasting Insulin × Fasting Glucose) ÷ 405. It gives a more complete picture than either number alone. It's not routinely calculated or reported on standard lab panels — which is one reason insulin resistance is so frequently missed until it's more advanced. Your HOMA-IR is calculated from your fasting insulin and glucose values. Published PMOS research has associated scores above 2.0 with a meaningful pattern of insulin resistance. Your healthcare provider is the right person to determine what this means for your individual care.
Print it and bring it to your appointment as research context — not as a directive. The guide shows your values alongside the PMOS research that informed each interpretation, with direct citations from published studies. A useful framing: "I came across some research on PMOS (you may know it as PCOS) and insulin levels — this summarizes what I found. Does it change how you look at my results?" Most providers respond well to specific, researched questions.
Not at all — this report worked with the values you entered, and even a few markers tell a meaningful story. Where a missing value would have added useful context, the report notes it, and Section 6 flags which numbers to prioritize at your next blood draw. When you're ready for a fuller picture, the lab guide in your report links to where you can order a complete panel without a doctor's referral — lab costs are billed separately by Ulta Lab Tests. Each time you add more data, your next report gets sharper.
Every 8–12 weeks while you're actively working on your pattern. That's the timeframe in which meaningful changes in the HOMA-IR score and SHBG typically become visible. Each new report becomes a comparison point. Section 6 in every report tells you specifically which numbers to prioritize at the next draw.
A companion report. You enter everything you're currently taking and it checks your stack against your specific lab results — what the research supports for your pattern, what may be redundant, anything that could be working against you, and what might be worth asking about. It's $97 on its own, or just $50 when you add it to this report.
Every interpretation in your report is grounded in peer-reviewed research, not opinion or generic templates.
Each marker is interpreted against the peer-reviewed PMOS literature, with the specific studies cited in your doctor's guide so you and your provider can check the source.
The Kascade Health™ framework was developed by a PhD chemist who has spent years in metabolic and hormonal-health research — the same rigor applied to your numbers.
This is educational context designed to make your next appointment more productive — always alongside your provider, never instead of them.